SG11201601477VA - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
SG11201601477VA
SG11201601477VA SG11201601477VA SG11201601477VA SG11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
SG11201601477VA
Other languages
English (en)
Inventor
Maharaj K Sahib
Jeetendra Kashinath Ambulge
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of SG11201601477VA publication Critical patent/SG11201601477VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11201601477VA 2013-09-30 2014-09-29 Pharmaceutical composition SG11201601477VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3124MU2013 IN2013MU03124A (cg-RX-API-DMAC10.html) 2013-09-30 2014-09-29
PCT/IB2014/064922 WO2015044922A1 (en) 2013-09-30 2014-09-29 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
SG11201601477VA true SG11201601477VA (en) 2016-04-28

Family

ID=51903957

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201601477VA SG11201601477VA (en) 2013-09-30 2014-09-29 Pharmaceutical composition

Country Status (10)

Country Link
US (1) US20160271226A1 (cg-RX-API-DMAC10.html)
EP (1) EP3052114A1 (cg-RX-API-DMAC10.html)
JP (1) JP2016531847A (cg-RX-API-DMAC10.html)
CN (1) CN105579052A (cg-RX-API-DMAC10.html)
AU (1) AU2014326181A1 (cg-RX-API-DMAC10.html)
BR (1) BR112016006963A2 (cg-RX-API-DMAC10.html)
IN (1) IN2013MU03124A (cg-RX-API-DMAC10.html)
RU (1) RU2016107610A (cg-RX-API-DMAC10.html)
SG (1) SG11201601477VA (cg-RX-API-DMAC10.html)
WO (1) WO2015044922A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108712910A (zh) * 2016-02-25 2018-10-26 沃克哈特有限公司 胰岛素和氨基酸的药物组合物
CN106729639B (zh) * 2017-01-10 2018-02-27 鲁南制药集团股份有限公司 一种甘精胰岛素注射液及其制备方法
PL4019039T3 (pl) 2017-07-27 2024-03-18 Adocia Kompozycje w postaci wodnego roztworu do wstrzykiwania zawierające co najmniej insulinę ludzką a21g i co najmniej jeden supresor glukagonu o działaniu posiłkowym
US20220280614A1 (en) * 2019-08-02 2022-09-08 Case Western Reserve University Premixed Ultra-Stable Single-Chain Insulin Analogue Formulations
EP3915572A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action
EP3915571A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3316363A1 (de) 1983-05-05 1984-11-08 Deutsche Babcock Anlagen Ag, 4200 Oberhausen Walzenrost fuer muellverbrennungsanlagen
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (da) 1988-05-11 1988-05-11 Novo Industri As Nye peptider
HUT56857A (en) 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
IL93282A (en) 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogues
DK155690D0 (da) 1990-06-28 1990-06-28 Novo Nordisk As Nye peptider
AU2003218635A1 (en) * 2002-05-07 2003-11-11 Novo Nordisk A/S Soluble formulations comprising insulin aspart and insulin detemir
PL1883394T3 (pl) * 2005-05-23 2018-09-28 Sdg, Inc. Konstrukt lipidowy do dostarczania insuliny ssakowi
KR101389226B1 (ko) * 2005-05-23 2014-04-25 에스디지,인코포레이티드 포유동물에게 인슐린을 전달하기 위한 지질 구조물
US20070086952A1 (en) 2005-09-29 2007-04-19 Biodel, Inc. Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7713929B2 (en) * 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
CN101454019A (zh) * 2006-04-12 2009-06-10 百达尔公司 速效和长效胰岛素联合制剂
WO2007121256A2 (en) 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
US8575096B2 (en) 2007-08-13 2013-11-05 Novo Nordisk A/S Rapid acting insulin analogues
CN101796071A (zh) 2007-08-13 2010-08-04 诺沃-诺迪斯克有限公司 快速作用的胰岛素类似物
US20120035103A1 (en) 2010-01-29 2012-02-09 Pillion Dennis J Method for administration of insulin and pharmaceutical composition thereof
WO2012080320A1 (en) * 2010-12-14 2012-06-21 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
WO2013021143A1 (fr) 2011-08-10 2013-02-14 Adocia Solution injectable d'au moins une insuline basale

Also Published As

Publication number Publication date
EP3052114A1 (en) 2016-08-10
IN2013MU03124A (cg-RX-API-DMAC10.html) 2015-07-31
AU2014326181A1 (en) 2016-03-17
RU2016107610A (ru) 2017-11-03
JP2016531847A (ja) 2016-10-13
CN105579052A (zh) 2016-05-11
US20160271226A1 (en) 2016-09-22
WO2015044922A1 (en) 2015-04-02
BR112016006963A2 (pt) 2017-08-01

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical preparations
SMT201900684T1 (it) Composizione farmaceutica combinata
PL2943181T3 (pl) Kompozycje farmaceutyczne
GB201322602D0 (en) Pharmaceutical compounds
GB201306610D0 (en) Pharmaceutical compounds
ZA201408333B (en) Pharmaceutical compositions
LT2961388T (lt) Vaistų deriniai
PL3043778T3 (pl) Kompozycje farmaceutyczne zawierające refametinib
ZA201602047B (en) Pharmaceutical compounds
SG11201509856RA (en) Pharmaceutical preparation
HUP1300496A2 (hu) Stabil kombinációs gyógyszerkészítmény
GB201312386D0 (en) Pharmaceutical compounds
IL244365A0 (en) pharmaceutical preparation
AP2015008890A0 (en) Pharmaceutical compositions
GB201304699D0 (en) Pharmaceutical compositions
GB201317166D0 (en) Pharmaceutical compounds
GB201304625D0 (en) New pharmaceutical composition
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions
GB201316662D0 (en) Pharmaceutical Combination
GB201310496D0 (en) Pharmaceutical combinations
GB201301723D0 (en) Pharmaceutical combinations
GB201316791D0 (en) Pharmaceutical Compounds
GB201316780D0 (en) Pharmaceutical compounds
GB201315733D0 (en) Pharmaceutical compounds